Literature DB >> 16572201

Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment.

M Trbusek, J Malcikova, J Smardova, V Kuhrova, D Mentzlova, H Francova, S Bukovska, M Svitakova, P Kuglik, V Linkova, M Doubek, Y Brychtova, J Zacal, J Kujickova, S Pospisilova, D Dvorakova, J Vorlicek, J Mayer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16572201     DOI： 10.1038/sj.leu.2404195

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.

Authors:  Matthew J J Rose-Zerilli; Jade Forster; Helen Parker; Anton Parker; Ana E Rodríguez; Tracy Chaplin; Anne Gardiner; Andrew J Steele; Andrew Collins; Bryan D Young; Anna Skowronska; Daniel Catovsky; Tatjana Stankovic; David G Oscier; Jonathan C Strefford
Journal:  Haematologica       Date:  2014-02-28       Impact factor: 9.941

Review 2.  IGHV mutational status testing in chronic lymphocytic leukemia.

Authors:  Jennifer Crombie; Matthew S Davids
Journal:  Am J Hematol       Date:  2017-07-29       Impact factor: 10.047

3.  Detection and clinical significance of genes in primary gastrointestinal MALT lymphoma.

Authors:  Guo-Ping Zhang; Peng-Fei Cao; Li-Juan Feng
Journal:  Tumour Biol       Date:  2013-11-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.